The ectopeptidases angiotensin-converting enzyme (ACE) and neprilysin cleave angiotensin and bradykinin peptides, which are important in adipose tissue physiology. Recently, both enzymes have been shown to be involved in outside-in signaling in endothelial cells. The purpose of this study is to confi rm signaling activities of ACE and neprilysin in human adipose cells. Methods: Preadipocytes were obtained from subcutaneous human adipose tissue and differentiated in vitro. Expression of ACE and neprilysin was quantitated by western blotting and phosphorylation assayed after labeling of cells with radioactive phosphate, followed by immunoprecipitation. Results: Expression of neprilysin in human preadipocytes is strongly upregulated during in vitro differentiation, while ACE is slightly downregulated. Both enzymes are phosphorylated, but phosphorylation is not regulated by angiotensin I or II and, unexpectedly, incubation of the cells with cell-permeable casein kinase II inhibitors did not diminish phosphorylation. Conclusions: This is the fi rst report of endogenous phosphorylation of ACE and neprilysin in human preadipocytes and adipocytes. In contrast to endothelial cells, however, phosphorylation does not seem to be mainly dependent on casein kinase II. Future studies will discern if phosphorylation is regulated by other ligands of the extracellular domains and may itself regulate protein-protein interactions, localization to rafts, enzyme activity or ectodomain shedding. Aims: To defi ne the involvement of matrix metalloproteinases (MMPs) in the control of human adipose tissue (AT) development and to determine whether HIV protease inhibitors (PIs) may interact with MMPs in the control of adipogenesis. Methods: Stromal human preadipocytes isolated from human subcutaneous AT were cultured in adipogenic medium with PIs (5 to 50 µM) or MMP inhibitors (1 and 5 µM) for 10 days. The adipocyte differentiation was studied by the measurement of lipogenic and lipolytic markers. Expression and secretion of MMPs were also determined as well as the potency of the inhibitors on the activity of human recombinant MMPs. Results: MMP inhibitors and PIs inhibited human adipocyte differentiation as observed by the decrease of cellular protein and/or triglyceride contents and expression of the fatty acid binding protein and the hormone-sensitive lipase. PIs are devoid of any effect on MMP activities. However, PIs were able to reduce specifi cally MMP-9 expression and release. Conclusions: These data suggest that MMPs and more precisely MMP-9 might be a key regulator of human AT development. They also suggest that PIs, by affecting the production of MMP-9, may promote human AT atrophy observed mostly in HIV-infected patients treated with PIs. Aims: We investigated the putative interaction between human adipocytes and blood monocytes through the adipose tissue(AT)-derived capillary endothelial cells (ECs).
Aims: To defi ne the involvement of matrix metalloproteinases (MMPs) in the control of human adipose tissue (AT) development and to determine whether HIV protease inhibitors (PIs) may interact with MMPs in the control of adipogenesis. Methods: Stromal human preadipocytes isolated from human subcutaneous AT were cultured in adipogenic medium with PIs (5 to 50 µM) or MMP inhibitors (1 and 5 µM) for 10 days. The adipocyte differentiation was studied by the measurement of lipogenic and lipolytic markers. Expression and secretion of MMPs were also determined as well as the potency of the inhibitors on the activity of human recombinant MMPs. Results: MMP inhibitors and PIs inhibited human adipocyte differentiation as observed by the decrease of cellular protein and/or triglyceride contents and expression of the fatty acid binding protein and the hormone-sensitive lipase. PIs are devoid of any effect on MMP activities. However, PIs were able to reduce specifi cally MMP-9 expression and release. Conclusions: These data suggest that MMPs and more precisely MMP-9 might be a key regulator of human AT development. They also suggest that PIs, by affecting the production of MMP-9, may promote human AT atrophy observed mostly in HIV-infected patients treated with PIs. Aims: We investigated the putative interaction between human adipocytes and blood monocytes through the adipose tissue(AT)-derived capillary endothelial cells (ECs).
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Methods:
The cells from the stroma-vascular fraction (SVF) and the mature adipocytes from human AT were isolated by collagenase digestion. FACS analysis of the SVF was performed and the CD14 + cells as well as the ECs were isolated using antibodies-coupled microbeads. The conditioned media obtained after 24h-incubation of adipocytes in fi brin gels were applied to the AT-derived ECs and the adhesion and transmigration of human monocytes was investigated by fl uorescence microscopy. Results: FACS analysis showed that 11% of the SVF is composed of CD14 + /CD31 + cells, characterized as resident macrophages. A positive correlation was found between the body mass index and the content of resident macrophages. Incubations of AT-derived ECs with adipocyte-conditioned media led to an up-regulation of endothelial adhesion molecules, and were associated with an increased chemotaxis of blood monocytes. Moreover, the effect of the adipocyte-conditioned medium was mimicked by human recombinant leptin.
Conclusions: The present study shows that the number of AT-resident macrophages increased with the fat mass and that mature adipocytederived factors activate ECs, leading to an enhanced chemotaxis of blood monocytes, probably through the production of leptin. The results demonstrate that mature adipokines activate ECs, leading to an enhanced diapedesis of blood monocytes. Aims: The cannabinoid receptor type 1 (CB1) is involved in food intake. Furthermore, the presence of peripheral CB1 receptors on rodent adipocytes has recently been demonstrated, and CB1 receptor antagonists increased expression of the adiponectin gene and activated lipogenic enzymes. Methods: We studied CB1 gene expression in lean and obese postmenopausal women at baseline (n = 88), and during dietary weight reduction (n = 15). All volunteers were characterized by anthropometry and clinical chemistry. RNA was isolated from adipose tissue obtained by subcutaneous abdominal biopsy. Gene expression was analyzed by TaqMan-RT-PCR. Western blots were used to demonstrate CB1 in adipocyte lysates.
Results: CB1 receptors were demonstrated on the RNA and protein level in mature isolated human adipocytes. The women included in this study were divided by BMI into lean (23 kg/m 2 ), overweight (28 kg/m 2 ), and obese (35 kg/m 2 ) groups. The groups were of similar age (56 vs. 57 vs. 58 years). CB1 gene expression tended to be highest in the overweight group, but no statistical signifi cant difference was found. 15 of these women were biopsied again after achieving 5 % body weight reduction (11-13 weeks). Although body fat, insulin resistance and other obesityassociated variables were reduced, 5 % body weight loss did not infl uence adipose-tissue gene expression of the CB1 receptor. Conclusions: Further studies are needed to clarify the physiological and pathophysiological roles of adipocyte CB1 receptors in obesity. Aims: We previously demonstrated that Haptoglobin (Hp), a glycoprotein involved in the acute phase response to infl ammation, is present in the white adipose tissue (WAT) of rodents and that Hp gene expression is upregulated in obese models. The aim of the present study was to establish whether Hp could be considered a marker of obesity in humans. Methods: Serum Hp was assessed by nephelopmetry in 312 individuals (BMI range 17.6-57.9 Kg/m 2 ) and analyzed against age, serum leptin, insulin, glucose, triglyceride and C-reactive protein (CRP). In 88 individuals fat mass was assessed by Dual Energy X-ray Absorptiometry. Northern and Western blot analyses were performed using total RNA and protein isolated from biopsies of WAT from 20 individuals. Results: In the total population serum Hp was positively correlated with BMI, leptin, triglycerides, CRP and age. When the two sexes were considered separately, in the females only we found signifi cant correlation between Hp and all these variables, whereas in the male group Hp was signifi cantly related to CRP and age. Serum Hp was positively associated with body fat, both in females and in males. We showed the presence of Hp mRNA and protein in the human WAT. Conclusions: Haptoglobin is a novel adipokine, and it can be used as a reliable marker of adiposity in humans. Aims: Primary culture of human preadipocytes is an in vitro model currently used for long-term study of human adipocyte differentiation which remains very poorly characterized. The present study was done to defi ne the metabolic pathways involved in triglyceride (TG) synthesis and the infl uence of hypoxia in such a model. Methods: Human preadipocytes from stroma-vascular cells of subcutaneous adipose tissue were cultured in adipogenic medium. At several stages of differentiation, parameters associated with adipocyte metabolism and differentiation were analyzed. In parallel, preadipocytes were submitted to hypoxia (5% O 2 ) and TG cellular content was assessed. Results: During adipocyte differentiation, TG accumulation and increased expression of HSL and aP2 were associated with a surprising decrease in lactate secretion as well as glucose uptake and transport. The expression of key enzymes involved in glyceroneogenesis (PEPCK) and de novo lipogenesis (FAS, ACC) was increased. The aim of the study was to investigate the role of oxLDL, involved in the pathogenesis of obesity-associated diseases such as atherosclerosis and type 2 diabetes, on preadipocyte 3T3.L1 cell differentiation. To this purpose, differentiating cells were exposed to oxLDL and the progression of differentiation was evaluated by morphological analysis and the expression of aP2, PPARγ, and pref-1. 3T3.L1 cells, induced to differentiate by hormonal mixture (1mM insulin, 0.26 mM dexamethazone, 0.5nM isobutyl-metyl-xantine), were cultured in DMEM until day 7. OxLDL (0.05 mg protein/ml) was added to the cells together with the differentiation mixture and maintained in the medium during the entire experimental time. Total RNA was daily isolated to study the mRNA expression of selected genes by RT-PCR and lipid storage was monitored by Oil-Red O staining. Moreover, cytosol and nuclear proteins were extracted separately and analysed by Western Blot. OxLDL-treated cells did not differentiate and, unlike differentiating control cells, showed: (i) lack of the intracellular lipid accumulation, (ii) lack of the increase of PPARγ mRNA level, (iii) a signifi cant overexpression of Pref-1 gene, and (iv) a decrease of PPARγ protein expression. It is worth noting that the PPARγ agonist troglitazone was able to overcome the inhibitory effects of oxLDL. This study demonstrated that oxLDL was able to delay 3T3.L1 preadipocyte differentiation, interfering with the normal sequence of events, leading to mature cell appearance. Aims: Ineffi cient oxidation of fuel molecules may contribute to reduced adiposity, and is a metabolic feature of brown adipose tissue (BAT), thanks to the specifi c expression of uncoupling protein 1 (UCP1). The aim of this work was to analyse the in vivo effect of retinoic acid (RA), the acid form of vitamin A and a known inductor of UCP1 in BAT, on the expression of UCP1 in WAT depots. Methods: mRNA levels of UCP1 and other transcripts related to fatty acid oxidation and thermogenesis, such as carnitine-palmitoyl transferase 1 (CPT-1) and PPARγ coactivator 1α (PGC-1α), were analysed by RT-PCR in BAT and WAT depots (inguinal, retroperitoneal and epididymal) of adult NMRI male mice treated with all-trans RA (at 10, 50 or 100 mg/kg/day, during the 4 days preceding sacrifi ce). Body weight, fat pad weight and serum non-esterifi ed fatty acids (NEFA) were also determined. Results: Treatment with RA reduced the weight of all fat pads without a concomitant increase of circulating NEFA levels, and induced the expression of UCP1 mRNA in all white fat depots studied and of PGC-1α mRNA and CPT-1 mRNA in some of them. Conclusions: Our results underscore the idea of adipose tissue plasticity, and suggest that RA may promote the acquisition of BATlike properties in WAT depots. Aims: It has previously been shown that transgenic expression of uncoupling protein1 (UCP1) in the white adipose tissue of mice (aP2-Ucp1 mice) protects these animals against obesity and that the ectopic UCP1 in white adipocytes decreases fatty acid synthesis and promotes mitochondrial biogenesis, while depressing intracellular energy charge. The AMP-activated protein kinase (AMPK) is activated by decreases in the ATP/AMP ratio. Once activated, this kinase preserves cellular ATP levels by stimulating ATP-producing pathways (e.g., mitochondrial biogenesis) and inhibiting ATP-consuming pathways (e.g., fatty acid synthesis). An aim was therefore to investigate whether the reduction in the ATP/AMP ratio induced by the ectopic UCP1 would lead to activation of AMPK in white adipose tissue. Methods: Subcutaneous and epididymal white fat depots were removed from control aP2-Ucp1 mice. ATP/AMP ratios, AMPK activity and PPAR gamma mRNA levels were measured in the two fat depots from both groups. Results: In both the fat depots, compared to control animals, the ATP/AMP ratio was lower in the aP2-Ucp1 transgenic mice. Ectopic expression of UCP-1 resulted in a signifi cant 2-fold increase in AMPK activity in subcutaneous fat tissue. These alterations in AMPK activity were refl ected by a decrease in PPAR gamma mRNA levels.
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Conclusions:
The results suggest that the metabolic alterations that protect aP2-Ucp1 mice from obesity are likely to be mediated by the AMPK. Regulation of PPAR gamma expression by AMPK may be involved in obesity resistance. Methods: Epididymal fat tissue was obtained from male SpragueDawley rat. The fat tissue was minced and incubated in PBS containing BSA, Hepes, type IV collagenase and antibiotics. Digested tissue was mechanically disrupted and passed through a 100 µm nylon mesh. Cells were collected and suspended in 11% Nycodenz and fractionated through a discontinuous Nycodenz gradient (11%, 13%, 19% and 30 % wt/vol). Cells were divided into four fractions. Cells in the various fractions were collected and cultured in DMEM containing 10% FBS. After 7 days in culture, adipogenic differention was induced by culturing the cells for 1 week in adipogenic medium (0.5 mM IBMX, 1uM dexamethasone, 10µM insulin) and assessed using an Oil Red O stain as an indicator of intracellular lipid accumulation. Results: Almost 70 % of cells from the total fraction remained in the light-density layers, F-1 (<11 % Nycodenz). However, the cells from F-2 (11-13 % Nycodenz interface) contained the highest percentage of adipogenic differentiation. The level of adipogenic differentiation was higher in F-2 compared to the unseparated cell fraction, which had low potential for differentiation. Conclusions: Taken together, the results indicate that density fractionation of fat tissue after Nycodenz gradient separation is a useful approach for mesenchymal stem cell enrichment. Aims: Adipose tissue (AT) produces factors involved in cardiovascular, infl ammatory and metabolic regulations, which are collectively called adipokines. Adrenomedullin (AM) is a potent vasodilating peptide acting also as an antioxidant and growth factor. The main source of circulating AM is believed to be the vascular walls. We searched for AM expression in human AT. Methods: We used immunohistochemistry and in situ hybridization on subcutaneous and visceral AT (SAT and VAT) obtained from 10 lean and 12 obese women, and primary cultures of human preadipocytes undergoing in vitro differentiation. Results: In controls, AM immunoreactivity (AM IR) and AM mRNA were found in vessel walls, stromal cell clusters, and isolated stromal cells, whereas adipocytes were not labeled. The levels of expression of AM IR and AM mRNA were comparable between SAT and VAT. In vitro, AM secretion from undifferentiated preadipocytes was high, then decreased steadily with time, being very low when preadipocytes began to differentiate into adipocytes. We show that AM IR and AM mRNA levels were signifi cantly decreased in SAT and VAT obtained from obese women as compared with controls (3264 ± 338 vs 4950 ± 370, p = 0.0029, and 3325 ± 294 vs 4829 ± 501 µm 2 /fi eld, p = 0.0300; 0.24 ± 0.05 vs 0.53 ± 0.13, p = 0.0064, and 0.29 ± 0.09 vs 1.02 ± 0.24 nCi/g/mm 2 , p = 0.0036, respectively). Conclusions: Our data demonstrate that AM is synthesized by the stromal portion of human SAT and VAT. Therefore, AM should be considered as a new adipokine. AT AM could be involved in AT growth regulation and participate in circulating AM. , 10 -5 and 10 -4 M) and noradrenaline (NA) 10 -7 M (in order to induce UCP1 mRNA expression). UCP1 and 2 mRNA levels were analyzed by Northern blot. Results: RU486 enhanced UCP1 mRNA NA-induced expression in a dose-dependent manner and had no signifi cant effect on UCP2 mRNA. Conclusions: RU486 is not only able to activate BAT by sympathetic stimulation (by its effects on the central nervous system, as has been suggested before), it can also directly regulate UCP1 expression in brown adipocytes, suggesting a possible role of this steroid in the thermogenic function. Aims: To get insight into the regulation of adipose cell proliferation and differentiation through the study of lipomatosis in highly active antiretroviral therapy (HAART)-treated AIDS patients. Methods: Biopsies of lipomas from HAART-treated patients were obtained by liposuction or surgery. The effects of drugs used in HAART on cell morphology and gene expression were tested on a cell model of primary murine brown adipocytes in culture. Results: HAART-associated lipomas express UCP1 mRNA, whereas UCP1 mRNA expression is barely detected in non-lipoma subcutaneous adipose tissue. Expression of PGC-1α mRNA is also increased in lipomas. Nucleoside reverse transcriptase inhibitors (NRTIs) cause a reduction in mitochondrial DNA content in cultured brown adipocytes, but gene expression for the mitochondrial oxidative machinery is not impaired. Stavudine causes a specifi c induction of UCP1 and PGC-1α gene expression. The non-NRTI nevirapine causes an overall increase in gene markers of brown adipocyte including mitochondrial biogenesis. Conclusions: Disturbances of brown with respect to white adipocyte biology are implicated in HAART-induced lipomatosis. Mitochondrial depletion does not appear as the unique mechanism explaining these effects on brown adipocytes, as evidenced by the existence of compensatory mechanisms to ensure mitochondrial DNA expression. Aims: The adipose tissue plays a key role in the development of obesity, and its implication in the regulation of appetite has been widely demonstrated since the discovery of leptin. As the endocannabinoid system has been largely involved in the balance of food intake, we investigated the presence of this system in the human adipose tissue. Methods: Primary cultures of human adipocyte precursors were conducted. Expression analysis of CB1 and CB2 receptors was realized by real-time RT-PCR, western blot and immunocytochemistry. The expression of fatty acid amide hydrolase (FAAH) was quantifi ed by RT-PCR. Results: We showed the presence of both receptors in cells purifi ed from visceral (epiploon) and subcutaneous fat. These receptors were expressed very early on the membrane of adipocyte precursors. Concerning CB1, this expression showed little variation among cells differentiation, while CB2 seemed to be correlated to adipocyte cellular development. The presence of FAAH, an enzyme responsible for hydrolysis of anandamide, has been determined as well, and the expression of this gene increased along the differentiation process. Conclusions: Our results identifi ed a new system in adipose tissue that could be partially responsible for the regulation of adipocyte differentiation. The presence of FAAH suggests that this tissue is able to secrete endocannabinoids. This brings new perspectives on the regulation of appetite by adipose tissue.
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T2:P2c-020
THE PROTEOMICS OF ADIPOSE TISSUE Rolland Catherine, Cash Philip, Broom Iain University of Aberdeen, Scotland, UK Aims: (1) To establish reliable protocols for the analysis of adipose tissue proteins on a global scale. (2) To determine differential protein expression between different fat depots within the body (3) To initiate the development of a proteomic database for human adipose tissue. Methods: 11 paired samples of subcutaneous and omental fat were collected from patients undergoing surgery for either laparatomy or heart bypass. Proteins were extracted from tissue samples and analyzed by two-dimensional gel electrophoresis (2DGE). Computer-assisted densitometry was used to compare the 2D protein profi les to locate differentially expressed cellular proteins. Selected proteins were excised following 2DGE and identifi ed by peptide mass mapping using MALDI-TOF MS. Results: Reproducible protein profi les were obtained from subcutaneous and omental tissues following analysis by 2DGE. Both quantitative and qualitative differences in protein expression were demonstrated with approximately 10-15% of the detected proteins exhibiting signifi cant differences in expression between the two tissues. Selected proteins are currently being identifi ed using peptide mass mapping. Conclusions: We have demonstrated the feasibility of 2DGE to defi ne the adipose tissue proteome. Proteins exhibiting differential patterns of expression between different fat depots are being identifi ed and these will form the basis of our long-term studies of the adipose proteome in specifi c disease syndromes and drug treatment. Aims: 1) To defi ne the ontogeny of PPAR-γ/ PGC-1α/UCP-1 expression in brown adipose tissue (BAT) and 2) to observe if the developmental decrease in the postnatal response of BAT to a beta adrenergic agonist (isoprenaline) is due to decreased expression of PPAR-γ/PGC-1α. Methods: Perirenal BAT samples were collected from pre-and post-natal (control and isoprenaline treated) lambs. Messenger RNA expression was determined by Northern hybridisation or real-time PCR.
Results: UCP-1 expression followed a bell-shaped curve peaking at birth. PGC-1α followed a similar curve, but preceded changes in UCP-1 expression. PPAR-γ expression paralleled PGC-1α expression in the pre natal life, declining around birth and increasing later in postnatal life. Isoprenaline signifi cantly increased UCP-1 mRNA expression compared to controls. PPAR-γ/PGC-1α did not show consistent responses to isoprenaline. Moreover, PGC-1α expression was not clearly linked to UCP-1 response to isoprenaline despite the evidence in rodents, which indicated that PGC-1α is responsive to cold exposure.
Conclusions:
The data suggest that the loss of PGC-1α in postnatal life could be one of the key switches in the developmental transformation of BAT into white adipose tissue. Method: Subcutaneous and omental adipose tissue was obtained from a female donor aged 36 years with a body mass index (BMI) of 33 kg/m 2 . Stromal vascular cells were isolated and cultured using modifi ed procedures described by Entenmann and Hauner. For the proliferation assay, stromal-vascular cells from subcutaneous and omental adipose tissue cultures were fed with proliferation media containing 0, 25 or 100 µM DHEA for 3 days. At the end of this treatment period, either of two type cultures were prepared for determining their metabolic activity using the Alamar Blue staining procedure. Results: The metabolic activity of proliferating human omental adipose tissue was higher than subcutaneous adipose tissue. The activity of proliferating human omental tissue cultures decreased more than the subcutaneous tissue as the level of DHEA in the cultures was increased. The amount of stainable lipid in the omental adipose tissue cultures treated with 25 and 100 µM DHEA was higher than the amount in the subcutaneous cultures. Conclusion: These data suggest that DHEA predominantly infl uences the proliferation and differentiation of human omental adipose tissue. Aims: To elucidate the mechanism responsible for enhanced differentiation of human preadipocytes in the presence of extracellular nucleotides acting on P2-receptors. Methods: Adipogenic conversion of human SGBS preadipocytes was induced by hormonal factors in serum-free medium in the presence of vehicle or nucleotides (50µM). Results: ATP and the stable β,γ-methylen-ATP (β,γATP), but not uridine nucleotides, induce increased (a) accumulation of triglycerides and (b) α-glycerophosphate dehydrogenase activity in cells treated for 4 to 8 days. The expression of fatty acid synthase and acetyl-CoA carboxylase are signifi cantly enhanced by ATP and β,γATP on day 4, but not on day 8 of differentiation. The expression of the protein kinase Akt, a key regulator of adipocyte metabolism, was not altered. However, on day 4, ATP and β,γATP potentiated phosphorylation of Akt on Ser473 and Thr308, indicating increased activation of the kinase. The expression of phosphoinositide 3-kinase subunits (p110α, p110β, p85α), which control activation of Akt, was not altered by nucleotides. Conclusions: Adenine nucleotides promote adipogenesis via increased expression and activity of key lipogenic enzymes. The activity of the protein kinase Akt must result from increased activity, not expression, of phosphoinositide 3-kinases. Therefore, the P2-receptor mediating the effect of ATP on differentiation may activate a phosphoinositide 3-kinase. Aims: To study differences in the concentration of preadipocytes, fat cells, and stromal cells between subcutaneous, omental, and mesenteric fat tissues in morbidly obese patients. Methods: Fat samples from the 3 sites were obtained from 9 individuals with BMI 41-65 kg/m 2 during gastric bypass surgery. DNA concentration was used to estimate total cell number. Fat cell concentration was derived from lipid per gram of tissue divided by the mean lipid content per fat cell. The difference between the total and fat cell numbers gave the stromal cell number. Fluorescent staining of cytospun stromal cells with an Ab against fatty acid-binding protein, aP2, marked preadipocytes (after a validation of aP2 as a preadipocyte marker in cultured and cloned preadipocytes). Since activated macrophages express aP2, a dual staining using antibodies against aP2 and CD68 was done to account for the macrophages (activated, aP2 + CD68
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+ and non-activated, aP2 -CD68 + ). The product of the proportion of each cell type and the stromal cell number gave the concentration of the preadipocytes and macrophages. Results: Omental tissue contained the highest number of stromal cells (means ± SE, in millions: 3.77 ± 1.58 vs. 1.35 ± 0.25 for subcutaneous, p < 0.01, and 2.46 ± 0.80 for the mesenteric), and non-activated macrophages (means ± SE, x 10 3 : 323 ± 65 vs. 157 ± 88 for subcutaneous, p < 0.01, and 240 ± 108 for the mesenteric). There were no depot differences in the number of preadipocytes and fat cells. Conclusions: In morbid obesity, fat cell number appears to be a fi xed characteristic of adipose tissue in all studied depots and seems to be controlled at the preadipocyte level. Macrophages and other stromal cellular fractions may be important in omental tissue pathophysiology. 
